An Astonishing New Device That Completely
Re-Grows New Teeth In Less Than 4 Months!
If you??ve read ??¡ÓThe Bad Breath
Report??, you know that a dramatic series of recent genetic
engineering breakthroughs have already allowed scientists to
completely regenerate lost teeth in animals and will be ready for
human use within a few years.
In the meanwhile, however, those who have lost
teeth can take-heart that a team of researchers at the University of
Alberta in Edmonton, Canada have developed an astonishing
non-invasive nanotechnology that will re-grow teeth in less than
4-months.
They filed patents for a tiny wireless ultrasonic
device -- dubbed LIPUS, for Low-Intensity Pulsed UltraSound -- in
2006.
Smaller than a pea, it gently massages gums and
stimulates tooth growth when mounted on braces or a temporary
plastic crown in a patient??s mouth. It is activated for 20 minutes a
day, over a period of 4-months.
The device was designed by Dr. Jie Chen, a
nano-biotechnologist at the University??s Engineering Department, and
is based on research carried-out by Dr. Tarek El-Bialy, an
Egyptian-born orthodontist, in the late 1990s.
In a study, published in the American Journal of
Orthodontics and Dentofacial Orthopedics, Dr. El-Bialy used
ultrasound on a rabbit that had undergone surgery on its jaw. He was
surprised to find that, as well as re-generating its jaw-bone, the
rabbit??s teeth also started to re-grow. He presented similar results
for human patients at the World Federation of Orthodontics in Paris
in September 2005.
The original ultrasonic devices were very big and,
thus, very uncomfortable for patients to hold in their mouth for 20
minutes at a time.
However, when he moved to the University of
Alberta, Dr. El-Bialy had a chance-encounter with Dr. Chen, and
other members of the engineering faculty, who joined forces with him
to radically miniaturise the technology.
According to Dr. Chen, as well as fixing broken
teeth, LIPUS may also be used to correct a crooked smile, and may,
eventually, allow people to grow taller by stimulating bone
growth.
It has been approved by both Canadian and American
regulatory bodies and a market-ready model is currently being
prepared. LIPUS is expected to be commercially available before the
end of 2009.
Return to Home
Page |